Comparison of two Medication Therapy Management Practice Models on Return on Investment

Abstract

Objective:

To compare the return on investment (ROI) of an integrated practice model versus a “hub and spoke” practice model of pharmacist provided medication therapy management (MTM).

Methods:

A cohort retrospective analysis of MTM claims billed in 76 pharmacies in North Carolina in the 2010 hub and spoke practice model and the 2012 “integrated” practice model were analyzed to calculate the ROI.

Results:

In 2010, 4089 patients received an MTM resulting in 8757 claims in the hub and spoke model. In 2012, 4896 patients received an MTM resulting in 13 730 claims in the integrated model. In 2010, US$165 897.26 was invested in pharmacist salary and $173 498.00 was received in reimbursement, resulting in an ROI of +US$7600.74 (+4.6%). In 2012, US$280 890.09 was invested in pharmacist salary and US$302 963 was received in reimbursement, resulting in an ROI of +US$22 072.91 or (+7.9%).

Conclusion:

The integrated model of MTM showed an increase in number of claims submitted and in number of patients receiving MTM services, ultimately resulting in a higher ROI. While a higher ROI was evident in the integrated model, both models resulted in positive ROI (1:12-1:21), highlighting that MTM programs can be cost effective with different strategies of execution.

Keywords

medication therapy management return on investment reimbursement community pharmacy medication review

Get full access to this article

View all access options for this article.

References

APhA MTM Digest. American Pharmacist Association. Web site. http://www.pharmacist.com/2013-mtm-digest. Published February 20, 2013. Accessed January 20, 2016.

American Pharmacists Association; National Association of Chain Drug Stores Foundation . Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc (2003). 2008;48(3):341–353. doi:10.1331/JAPhA.2008.08514.

Barnett

Frank

Wehring

. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm. 2009;15(1):18–31.

Branham

Katz

Moose

. Retrospective analysis of estimated cost avoidance following pharmacist-provided medication therapy management services. J Pharm Pract. 2013;26(4):420–427. doi:10.1177/0897190012465992.

Bunting

Smith

Sutherland

. The Asheville Project: clini- cal and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008;48(1):23–31.

Bunting

Cranor

. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medi- cation therapy management program for asthma. J Am Pharm As- soc. 2006;46(2):133–147.

Cranor

Bunting

Christensen

. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43(2):173–184.

Chater

Moczygemba

Lawson

. Building the business model for medication therapy management services. J Am Pharm Assoc (2003). 2008;48(1):16–22.

McDonough

Harthan

McLeese

. Retrospective financial analysis of medication therapy management services from the pharmacy’s perspective. J Am Pharm Assoc (2003). 2010;50(1):62–66.

10.

Ramalho de Oliveira

Brummel

Miller

. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm. 2010;16(3):185–195.

11.

Rhodes

Reynolds

Marciniak

. Evaluating the economic impact of a targeted medication intervention program. J Pharm Pract. 2013;26(6):562–573.

12.

NCPA Digest: In Brief. National Community Pharmacists Association. 2012. Web site. http://www.ncpanet.org/pdf/digest/2012/2012_digest_inbrief.pdf. Accessed at January 20, 2016.

13.

Bureau of Labor Statistics, U.S. Department of Labor, Occupational Outlook Handbook, 2014-15 Edition, Pharmacists, on the Internet at Web site. http://www.bls.gov/ooh/healthcare/pharmacists.htm. Accessed at May 06, 2015.

14.

Truong

Groves

Congdon

. Potential cost savings of medication therapy management in safety-net clinics. J Am Pharm Assoc (2003). 2015:55(3):269–272.